1. Home
  2. KURA vs LFMD Comparison

KURA vs LFMD Comparison

Compare KURA & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • LFMD
  • Stock Information
  • Founded
  • KURA 2014
  • LFMD 1994
  • Country
  • KURA United States
  • LFMD United States
  • Employees
  • KURA N/A
  • LFMD N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • LFMD Medical/Nursing Services
  • Sector
  • KURA Health Care
  • LFMD Health Care
  • Exchange
  • KURA Nasdaq
  • LFMD Nasdaq
  • Market Cap
  • KURA 492.9M
  • LFMD 552.6M
  • IPO Year
  • KURA N/A
  • LFMD N/A
  • Fundamental
  • Price
  • KURA $5.85
  • LFMD $14.76
  • Analyst Decision
  • KURA Strong Buy
  • LFMD Strong Buy
  • Analyst Count
  • KURA 12
  • LFMD 5
  • Target Price
  • KURA $24.50
  • LFMD $11.00
  • AVG Volume (30 Days)
  • KURA 1.3M
  • LFMD 1.8M
  • Earning Date
  • KURA 08-07-2025
  • LFMD 08-06-2025
  • Dividend Yield
  • KURA N/A
  • LFMD N/A
  • EPS Growth
  • KURA N/A
  • LFMD N/A
  • EPS
  • KURA N/A
  • LFMD N/A
  • Revenue
  • KURA $67,991,000.00
  • LFMD $234,007,330.00
  • Revenue This Year
  • KURA $109.86
  • LFMD $29.80
  • Revenue Next Year
  • KURA $107.90
  • LFMD $18.03
  • P/E Ratio
  • KURA N/A
  • LFMD N/A
  • Revenue Growth
  • KURA N/A
  • LFMD 43.07
  • 52 Week Low
  • KURA $5.41
  • LFMD $3.99
  • 52 Week High
  • KURA $23.48
  • LFMD $15.34
  • Technical
  • Relative Strength Index (RSI)
  • KURA 40.44
  • LFMD 76.69
  • Support Level
  • KURA $5.56
  • LFMD $12.10
  • Resistance Level
  • KURA $7.17
  • LFMD $13.15
  • Average True Range (ATR)
  • KURA 0.38
  • LFMD 0.89
  • MACD
  • KURA -0.06
  • LFMD 0.08
  • Stochastic Oscillator
  • KURA 6.05
  • LFMD 84.11

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Share on Social Networks: